280 related articles for article (PubMed ID: 12150827)
21. Loss of PTEN facilitates HIF-1-mediated gene expression.
Zundel W; Schindler C; Haas-Kogan D; Koong A; Kaper F; Chen E; Gottschalk AR; Ryan HE; Johnson RS; Jefferson AB; Stokoe D; Giaccia AJ
Genes Dev; 2000 Feb; 14(4):391-6. PubMed ID: 10691731
[TBL] [Abstract][Full Text] [Related]
22. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
Dijkers PF; Birkenkamp KU; Lam EW; Thomas NS; Lammers JW; Koenderman L; Coffer PJ
J Cell Biol; 2002 Feb; 156(3):531-42. PubMed ID: 11815629
[TBL] [Abstract][Full Text] [Related]
23. Regulation of C. elegans DAF-16 and its human ortholog FKHRL1 by the daf-2 insulin-like signaling pathway.
Lee RY; Hench J; Ruvkun G
Curr Biol; 2001 Dec; 11(24):1950-7. PubMed ID: 11747821
[TBL] [Abstract][Full Text] [Related]
24. Akt modulates STAT3-mediated gene expression through a FKHR (FOXO1a)-dependent mechanism.
Kortylewski M; Feld F; Krüger KD; Bahrenberg G; Roth RA; Joost HG; Heinrich PC; Behrmann I; Barthel A
J Biol Chem; 2003 Feb; 278(7):5242-9. PubMed ID: 12456685
[TBL] [Abstract][Full Text] [Related]
25. FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress.
Furukawa-Hibi Y; Yoshida-Araki K; Ohta T; Ikeda K; Motoyama N
J Biol Chem; 2002 Jul; 277(30):26729-32. PubMed ID: 12048180
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
[TBL] [Abstract][Full Text] [Related]
27. Negative regulation of the forkhead transcription factor FKHR by Akt.
Tang ED; Nuñez G; Barr FG; Guan KL
J Biol Chem; 1999 Jun; 274(24):16741-6. PubMed ID: 10358014
[TBL] [Abstract][Full Text] [Related]
28. Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead.
Martínez-Gac L; Marqués M; García Z; Campanero MR; Carrera AC
Mol Cell Biol; 2004 Mar; 24(5):2181-9. PubMed ID: 14966295
[TBL] [Abstract][Full Text] [Related]
29. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E
J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908
[TBL] [Abstract][Full Text] [Related]
30. Regulation of alkaline phosphatase promoter activity by forkhead transcription factor FKHR.
Hatta M; Daitoku H; Matsuzaki H; Deyama Y; Yoshimura Y; Suzuki K; Matsumoto A; Fukamizu A
Int J Mol Med; 2002 Feb; 9(2):147-52. PubMed ID: 11786925
[TBL] [Abstract][Full Text] [Related]
31. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins.
Scheijen B; Ngo HT; Kang H; Griffin JD
Oncogene; 2004 Apr; 23(19):3338-49. PubMed ID: 14981546
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin.
Arimoto-Ishida E; Ohmichi M; Mabuchi S; Takahashi T; Ohshima C; Hayakawa J; Kimura A; Takahashi K; Nishio Y; Sakata M; Kurachi H; Tasaka K; Murata Y
Endocrinology; 2004 Apr; 145(4):2014-22. PubMed ID: 14701673
[TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily.
Anderson MJ; Viars CS; Czekay S; Cavenee WK; Arden KC
Genomics; 1998 Jan; 47(2):187-99. PubMed ID: 9479491
[TBL] [Abstract][Full Text] [Related]
34. FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts.
Bois PR; Grosveld GC
EMBO J; 2003 Mar; 22(5):1147-57. PubMed ID: 12606579
[TBL] [Abstract][Full Text] [Related]
35. Forkhead family transcription factor FKHRL1 is expressed in human megakaryocytes. Regulation of cell cycling as a downstream molecule of thrombopoietin signaling.
Tanaka M; Kirito K; Kashii Y; Uchida M; Watanabe T; Endo H; Endoh T; Sawada K; Ozawa K; Komatsu N
J Biol Chem; 2001 May; 276(18):15082-9. PubMed ID: 11278373
[TBL] [Abstract][Full Text] [Related]
36. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
37. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.
Woods YL; Rena G; Morrice N; Barthel A; Becker W; Guo S; Unterman TG; Cohen P
Biochem J; 2001 May; 355(Pt 3):597-607. PubMed ID: 11311120
[TBL] [Abstract][Full Text] [Related]
38. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
39. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
Sublett JE; Jeon IS; Shapiro DN
Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
[TBL] [Abstract][Full Text] [Related]
40. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
